Risk factors analysis for hyperuricemic nephropathy among CKD stages 3–4 patients: an epidemiological study of hyperuricemia in CKD stages 3–4 patients in Ningbo, China

Yong-Yao Wu, Xiaohui Qiu, Yun Ye, Chao Gao, Fuquan Wu, Guihua XiaRenal 2018 · DOI

TL;DR

This study investigated the risk factors for hyperuricemic nephropathy (HN) in patients with Chronic Kidney Disease (CKD) stages 3-4. The findings highlight that serum uric acid (SUA) levels, along with factors like sex, age, BMI, and dietary habits, significantly contribute to the development of HN in this patient population.

What Problem Does This Paper Address?

Chronic kidney disease (CKD) is a significant health concern characterized by progressive loss of kidney function. Hyperuricemia, defined as elevated serum uric acid (SUA) levels, is increasingly recognized as a potential risk factor for CKD and its progression, particularly for a severe form known as hyperuricemic nephropathy (HN). While the association between hyperuricemia and CKD is established, the specific risk factors contributing to HN in patients with moderate-stage CKD (stages 3-4) remain incompletely understood. This paper aims to fill this knowledge gap by conducting an epidemiological study to identify these risk factors in a Chinese cohort.

Methods

The researchers recruited 461 CKD stages 3-4 patients and categorized them into three groups based on their 24-hour urine uric acid (UUA) excretion after a low-purine diet: normal, underexcreter, and overproduct types. They collected comprehensive clinical and biochemical data from these patients. Statistical analyses, including logistic regression and correlation analysis, were employed to identify independent risk factors for HN. Additionally, they investigated the correlation between the mRNA expression levels of two key urate transporters, hUAT and hURAT1, and serum uric acid (SUA) levels in a subset of patients.

Datasets

The study utilized data from 461 CKD stages 3-4 patients recruited from the Nephrology department of Beilun People's Hospital and the Beilun Branch of the First Affiliated Hospital of Zhejiang University in Ningbo, China, between August 2014 and July 2016. No new datasets or benchmarks were introduced.

Key Insights and Ideas

  • SUA is a central player: The study strongly reinforces that elevated serum uric acid (SUA) is a critical factor in the development of hyperuricemic nephropathy (HN) in CKD patients.
  • Beyond SUA: A multifactorial problem: While SUA is key, the research reveals that HN is not solely determined by uric acid levels. Other factors like sex, age, body mass index (BMI), waist-to-height ratio (WHR), and even dietary habits (specifically roasted fish consumption) and alcohol consumption play significant roles.
  • Urate transporters as potential indicators: The correlation found between the mRNA expression of urate transporters (hUAT and hURAT1) and SUA levels suggests these transporters might be involved in the development of HN and could potentially serve as biomarkers.
  • "Overproduct" type is at higher risk: Patients who overproduce uric acid (overproduct type group) exhibited significantly higher levels of various risk factors, including age, BMI, WHR, and SUA, indicating a heightened risk profile.

Key Results

  • The "overproduct type" group showed significantly higher average age, BMI, WHR, SUA levels, and HN ratio compared to the other groups.
  • Logistic regression analysis identified SUA, cholesterol (CHO), urine neutrophil gelatinase-associated lipocalin (uNgal/Cr.) ratio, and urine kidney injury molecule-1 (uKim-1/Cr.) ratio as independent risk factors for HN.
  • The HN morbidity was significantly higher in the overproduct (88.6%) and underexcreter (87.6%) UUA type groups compared to the normal UUA type group (68.4%).
  • A positive correlation was observed between the mRNA expression levels of hUAT and hURAT1 and SUA concentrations in underexcreter CKD patients.

Limitations and Future Work

The authors acknowledge that while their study identified associations, it does not definitively prove causality. Further interventional or experimental studies are needed to confirm the causal relationships and elucidate the underlying mechanisms linking these identified factors to HN. The study focused on CKD stages 3-4, so findings may not be directly generalizable to other CKD stages. Future research could explore these relationships in broader CKD populations and investigate therapeutic strategies targeting these identified risk factors.

Summary updated

Abstract

These results showed SUA and other characteristics contributed to HN morbidity in CKD 3-4 patients.
BibTeX
@inproceedings{wu2018risk,
  author = {Yong-Yao Wu and Xiaohui Qiu and Yun Ye and Chao Gao and Fuquan Wu and Guihua Xia},
  title = {{Risk factors analysis for hyperuricemic nephropathy among CKD stages 3–4 patients: an epidemiological study of hyperuricemia in CKD stages 3–4 patients in Ningbo, China}},
  booktitle = {Renal},
  year = {2018},
  doi = {10.1080/0886022x.2018.1487859},
}

Loading related content...

Figure